EKR Therapeutics Raises Over $13 Million in a Series C Financing Round From New and Existing Investors EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur a Novel Extended -Release Opioid Analgesic for Post Operative Pain